1. Home
  2. MRTN vs TBPH Comparison

MRTN vs TBPH Comparison

Compare MRTN & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marten Transport Ltd.

MRTN

Marten Transport Ltd.

N/A

Current Price

$13.16

Market Cap

1.1B

Sector

Industrials

ML Signal

N/A

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

N/A

Current Price

$19.26

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MRTN
TBPH
Founded
1946
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
MRTN
TBPH
Price
$13.16
$19.26
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$27.80
AVG Volume (30 Days)
696.8K
386.5K
Earning Date
04-27-2026
01-01-0001
Dividend Yield
1.83%
N/A
EPS Growth
N/A
N/A
EPS
0.17
0.88
Revenue
$1,131,455,000.00
$15,386,000.00
Revenue This Year
N/A
$70.90
Revenue Next Year
$10.12
N/A
P/E Ratio
$77.29
$21.66
Revenue Growth
N/A
N/A
52 Week Low
$9.35
$7.90
52 Week High
$14.78
$21.03

Technical Indicators

Market Signals
Indicator
MRTN
TBPH
Relative Strength Index (RSI) 52.77 45.07
Support Level $12.73 $18.27
Resistance Level $14.09 $19.04
Average True Range (ATR) 0.41 0.91
MACD -0.09 -0.09
Stochastic Oscillator 40.50 23.72

Price Performance

Historical Comparison
MRTN
TBPH

About MRTN Marten Transport Ltd.

Marten Transport Ltd is a temperature-sensitive truckload carrier in the United States. The company specializes in transporting and distributing food and other consumer packaged goods that require a temperature-controlled or insulated environment. It operates through four segments: Truckload, Dedicated, Intermodal, and Brokerage, generating the majority of its revenue from the Truckload segment. The Truckload segment offers a mix of regional short-haul and medium- to long-haul full-load transportation services.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: